PARP inhibition: PARP1 and beyond

被引:1055
作者
Rouleau, Michele [1 ]
Patel, Anand [2 ]
Hendzel, Michael J. [4 ]
Kaufmann, Scott H. [2 ,3 ]
Poirier, Guy G. [1 ]
机构
[1] Univ Laval, Med Res Ctr, Quebec City, PQ, Canada
[2] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
[3] Mayo Clin, Div Oncol Res, Rochester, MN USA
[4] Univ Alberta, Fac Med, Dept Oncol, Edmonton, AB T6G 2M7, Canada
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
POLY(ADP-RIBOSE) POLYMERASE INHIBITOR; ADENOSINE-DIPHOSPHATE-RIBOSE; DOUBLE-STRAND BREAKS; DNA-DAMAGING AGENTS; HUMAN GLIOMA-CELLS; HOMOLOGOUS RECOMBINATION; ADP-RIBOSYLATION; TELOMERE LENGTH; IN-VIVO; EMBRYONIC-DEVELOPMENT;
D O I
10.1038/nrc2812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent findings have thrust poly(ADP-ribose) polymerases (PARPs) into the limelight as potential chemotherapeutic targets. To provide a framework for understanding these recent observations, we review what is known about the structures and functions of the family of PARP enzymes, and then outline a series of questions that should be addressed to guide the rational development of PARP inhibitors as anticancer agents.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 141 条
  • [1] Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1
    Ahel, Dragana
    Horejsi, Zuzana
    Wiechens, Nicola
    Polo, Sophie E.
    Garcia-Wilson, Elisa
    Ahel, Ivan
    Flynn, Helen
    Skehel, Mark
    West, Stephen C.
    Jackson, Stephen P.
    Owen-Hughes, Tom
    Boulton, Simon J.
    [J]. SCIENCE, 2009, 325 (5945) : 1240 - 1243
  • [2] Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
    Albert, Jeffrey M.
    Cao, Carolyn
    Kim, Kwang Woon
    Willey, Christopher D.
    Geng, Ling
    Xiao, Dakai
    Wang, Hong
    Sandler, Alan
    Johnson, David H.
    Colevas, Alexander D.
    Low, Jennifer
    Rothenberg, Mace L.
    Lu, Bo
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (10) : 3033 - 3042
  • [3] Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites
    Altmeyer, Matthias
    Messner, Simon
    Hassa, Paul O.
    Fey, Monika
    Hottiger, Michael O.
    [J]. NUCLEIC ACIDS RESEARCH, 2009, 37 (11) : 3723 - 3738
  • [4] CHARACTERIZATION OF POLYMERS OF ADENOSINE-DIPHOSPHATE RIBOSE GENERATED INVITRO AND INVIVO
    ALVAREZGONZALEZ, R
    JACOBSON, MK
    [J]. BIOCHEMISTRY, 1987, 26 (11) : 3218 - 3224
  • [5] PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase
    Amé, JC
    Rolli, V
    Schreiber, V
    Niedergang, C
    Apiou, F
    Decker, P
    Muller, S
    Hoger, T
    Murcia, JMD
    de Murcia, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17860 - 17868
  • [6] The PARP superfamily
    Amé, JC
    Spenlehauer, C
    de Murcia, G
    [J]. BIOESSAYS, 2004, 26 (08) : 882 - 893
  • [7] Anders C, 2008, ONCOLOGY-NY, V22, P1233
  • [8] Poly(ADP-ribose) (PAR) polymer is a death signal
    Andrabi, Shaida A.
    Kim, No Soo
    Yu, Seong-Woon
    Wang, Hongmin
    Koh, David W.
    Sasaki, Masayuki
    Klaus, Judith A.
    Otsuka, Takashi
    Zhang, Zhizheng
    Koehler, Raymond C.
    Hurn, Patricia D.
    Poirier, Guy G.
    Dawson, Valina L.
    Dawson, Ted M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (48) : 18308 - 18313
  • [9] Drug Resistance Caused by Reversion Mutation
    Ashworth, Alan
    [J]. CANCER RESEARCH, 2008, 68 (24) : 10021 - 10023
  • [10] Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
    Audebert, M
    Salles, B
    Calsou, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) : 55117 - 55126